Histological and phenotypical flow cytometric analysis of IELs in duodenal biopsies before (1-6 mo) and after ASCT
| Patient . | Marsh category . | CD7+CD3−, % of CD103+ ly . | Cyt CD3+ surf CD3−, % of CD103+ ly . | CD8+, % of CD103+ ly . | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Before . | After . | Before . | After . | Before . | After . | Before . | After . | |||||||||
| 3 mo . | 12 mo . | 24 mo . | 3 mo . | 12 mo . | 24 mo . | 3 mo . | 12 mo . | 24 mo . | 3 mo . | 12 mo . | 24 mo . | |||||
| Patient A | III-A | III-A | III-A | I | 95 | 47 | 48 | 15 | 94 | 89 | 86 | 3 | 1 | 20 | 7 | 52 |
| Patient B | III-B | I | I | I | 51 | 7 | 4 | 8 | 51 | 2 | 6 | 4 | 28 | 68 | 62 | 67 |
| Patient C | III-C | III-A | III-A | — | 62 | 33 | 24 | — | 59 | 34 | 27 | — | 15 | 41 | 36 | — |
| Patient D | III-A | III-A | — | — | 54 | 47 | — | — | 81 | 78 | — | — | 7 | 13 | — | — |
| Patient E | III-B | I | — | — | 44 | 68 | — | — | 30 | 36 | — | — | 22 | 2 | — | — |
| Patient F | III-B | III-A | — | — | 71 | 40 | — | — | 50 | 31 | — | — | 23 | 11 | — | — |
| Patient G | III-C | III-A | — | — | 11 | 30 | — | — | 10 | 27 | — | — | 63 | 52 | — | — |
| Mean | — | — | — | — | 63 | 38 | — | — | 61 | 42 | — | — | 23 | 30 | — | — |
| Patient . | Marsh category . | CD7+CD3−, % of CD103+ ly . | Cyt CD3+ surf CD3−, % of CD103+ ly . | CD8+, % of CD103+ ly . | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Before . | After . | Before . | After . | Before . | After . | Before . | After . | |||||||||
| 3 mo . | 12 mo . | 24 mo . | 3 mo . | 12 mo . | 24 mo . | 3 mo . | 12 mo . | 24 mo . | 3 mo . | 12 mo . | 24 mo . | |||||
| Patient A | III-A | III-A | III-A | I | 95 | 47 | 48 | 15 | 94 | 89 | 86 | 3 | 1 | 20 | 7 | 52 |
| Patient B | III-B | I | I | I | 51 | 7 | 4 | 8 | 51 | 2 | 6 | 4 | 28 | 68 | 62 | 67 |
| Patient C | III-C | III-A | III-A | — | 62 | 33 | 24 | — | 59 | 34 | 27 | — | 15 | 41 | 36 | — |
| Patient D | III-A | III-A | — | — | 54 | 47 | — | — | 81 | 78 | — | — | 7 | 13 | — | — |
| Patient E | III-B | I | — | — | 44 | 68 | — | — | 30 | 36 | — | — | 22 | 2 | — | — |
| Patient F | III-B | III-A | — | — | 71 | 40 | — | — | 50 | 31 | — | — | 23 | 11 | — | — |
| Patient G | III-C | III-A | — | — | 11 | 30 | — | — | 10 | 27 | — | — | 63 | 52 | — | — |
| Mean | — | — | — | — | 63 | 38 | — | — | 61 | 42 | — | — | 23 | 30 | — | — |
Mean was calculated for values at 3 mo after ASCT. Normal range for Cyt CD3+ surf CD3−% of lymphocytes is 10% or less. TCRγ-PCR analysis showed monoclonality in all patients.
Ly indicates lymphocytes; —, not applicable; TCRγ-PCR analysis, T-cell receptor γ–polymerase chain reaction rearrangement.